Inventiva S.A.

IVA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001756594

SEC filings (opens in a new tab)

No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $319.5M in total; no superinvestor holds it.

Other share classesIVEVF

Q2 2026 vs. Q1 2026

How the institutions holding Inventiva S.A. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of IVA: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	65	1	88	+24
Shares	52.4M	2.35M	84.6M	+34.6M (+69.3%)
Value	$290.4M	$13.1M	$319.5M	+$42.2M (+15.2%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Inventiva S.A. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to IVA in Q2 2026
Institution	Shares	Value	% of portfolio
Nantahala Capital Management, LLC	2,686,393	$10.2M	0.61%
Woodline Partners LP	2,323,149	$8.78M	0.03%
Standard Life Aberdeen plc	2,307,773	$8.72M	0.01%
Patient Square Capital LP	1,967,171	$7.44M	1.15%
StemPoint Capital LP	1,426,320	$5.39M	0.93%
Kingdon Capital Management, L.L.C.	1,270,000	$4.80M	0.65%
JPMorgan Chase & Co	1,309,100	$4.65M	0.00%
Adage Capital Partners GP, L.L.C.	1,120,000	$4.23M	0.01%
Syquant Capital SAS	913,135	$3.45M	0.77%
Alyeska Investment Group, L.P.	909,000	$3.44M	0.01%
FMR LLC	685,400	$2.59M	0.00%
Qube Research & Technologies Ltd	397,558	$1.50M	0.00%
Ghisallo Capital Management LLC	250,000	$945.0K	0.02%
Burkehill Global Management, LP	225,000	$850.5K	0.03%
Seven Grand Managers, LLC	225,000	$850.5K	0.03%
Bank of America Corp	151,917	$574.2K	0.00%
Balyasny Asset Management LLC	144,181	$545.0K	0.00%
Walleye Capital LLC	135,648	$512.7K	0.00%
Rathbone Brothers plc	100,000	$378.0K	0.00%
Jefferies Financial Group Inc.	40,000	$151.2K	0.00%
R Squared Ltd	29,918	$113.1K	0.06%
Shay Capital LLC	21,871	$82.7K	0.01%
Royal Bank of Canada	15,741	$60.0K	0.00%
Ground Swell Capital, LLC	12,803	$48.4K	0.05%
Citigroup Inc	6,612	$25.0K	0.00%
Tower Research Capital LLC (TRC)	1,800	$6.80K	0.00%
Barclays PLC	1,781	$6.73K	0.00%
Stone House Investment Management, LLC	1,463	$5.53K	0.00%
Advisor Group Holdings, Inc.	308	$1.16K	0.00%
Larson Financial Group LLC	225	$851	0.00%
SRS Capital Advisors, Inc.	51	$193	0.00%

Sold out (7)

Institutions that held Inventiva S.A. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of IVA in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
RTW Investments, LP	1,298,702	$7.21M
Russell Investments Group, Ltd.	205,639	$1.14M
Prelude Capital Management, LLC	40,000	$222.0K
ExodusPoint Capital Management, LP	38,256	$212.3K
Virtu Financial LLC	18,729	$104.0K
Jones Financial Companies LLLP	881	$5.04K
EverSource Wealth Advisors, LLC	604	$3.35K

Not filed for Q2 2026 yet (1)

Institutions that held Inventiva S.A. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IVA in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
SymBiosis Capital Partners, LLC	2,354,000	$13.1M